Top

Published in:

01-02-2009 | Original Article

Medical Complications Drive Length of Stay After Brain Hemorrhage: A Cohort Study

Authors: Andrew M. Naidech, Bernard R. Bendok, Paul Tamul, Sarice L. Bassin, Charles M. Watts, H. Hunt Batjer, Thomas P. Bleck

Published in: Neurocritical Care | Issue 1/2009

Abstract

Introduction

Longer length of stay (LOS) is associated with higher complications and costs in ICU patients, while hospital protocols may decrease complications and LOS. We hypothesized that medical complications would increase LOS after spontaneous subarachnoid (SAH) and intracerebral (ICH) hemorrhage after accounting for severity of neurologic injury in a cohort of consecutively admitted patients.

Methods

We prospectively recorded admission characteristics, hospital complications, and LOS for 122 patients with SAH and 56 patients with ICH from February 2006 through March 2008. A multidisciplinary Neuro-ICU team included a dedicated pharmacist and intensivist on daily rounds. Hospital protocols set glucose control with intravenous insulin, ventilator bundles, pharmacist involvement, and hand hygiene. Associations were explored with univariate statistics (t-tests, ANOVA, or non-parametric statistics as appropriate) and linear regression (repeated after log transformation of ICU and hospital LOS).

Results

Factors associated with longer LOS after SAH and ICH were similar. In both SAH and ICH the strongest drivers of LOS were infection, fever, and acute lung injury. For SAH, vasospasm and Glasgow Coma Scale were also significant in some models, while in patients with ICH the volume of the initial bleed was significant in some models.

Conclusion

LOS after spontaneous brain hemorrhage is driven by medical complications even after the adoption of dedicated intensive care medical staff, pharmacist involvement, and evidence-based protocols for ICU care. Further alterations in care will be necessary to eliminate “preventable” complications and minimize LOS after brain hemorrhage.

Friedman JA, Pichelmann MA, Piepgras DG, McIver JI, Toussaint LG, McClelland RL, et al. Pulmonary complications of aneurysmal subarachnoid hemorrhage. Neurosurgery. 2003;52:1025–32. doi:10.1227/01.NEU.0000058222.59289.F1.PubMedCrossRef

Frontera JA, Fernandez A, Schmidt JM, Claassen J, Wartenberg K, Badjatia N, et al. Impact of nosocomial infectious complications after subarachnoid hemorrhage. Neurosurgery. 2008;62:80–7.PubMed

Rumbak MJ, Newton M, Truncale T, Schwartz SW, Adams JW, Hazard PB. A prospective, randomized, study comparing early percutaneous dilational tracheotomy to prolonged translaryngeal intubation (delayed tracheotomy) in critically ill medical patients. Crit Care Med. 2004;32:1689–94. doi:10.1097/01.CCM.0000134835.05161.B6.PubMedCrossRef

Myny D, Depuydt P, Colardyn F, Blot S. Ventilator-associated pneumonia in a tertiary care ICU: analysis of risk factors for acquisition and mortality. Acta Clin Belg. 2005;60:114–21.PubMed

Van den Berghe G, Wouters P, Weekers F, Verwalest C, Frans Bruyninckx MS, Vlasselaers D, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345:1359–67. doi:10.1056/NEJMoa011300.PubMedCrossRef

Van den Berghe G, Schoonheydt K, Becx P, Bruyninckx F, Wouters PJ. Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology. 2005;64:1348–53.PubMed

Pronovost P, Needham D, Berenholtz S, Sinopoli D, Chu H, Cosgrove S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med. 2006;355:2725–32. doi:10.1056/NEJMoa061115.PubMedCrossRef

Burger CD, Resar RK. “Ventilator bundle” approach to prevention of ventilator-associated pneumonia. Mayo Clin Proc. 2006;81:849–54.PubMed

Resar R, Pronovost P, Haraden C, Simmonds T, Rainey T, Nolan T. Using a bundle approach to improve ventilator care processes and reduce ventilator associated pneumonia. Jt Comm J Qual Patient Saf. 2005;31:243–8.PubMed

10.

Dries DJ, McGonigal MD, Malian MS, Bor BJ, Sullivan C. Protocol-driven ventilator weaning reduces use of mechanical ventilation, rate of early reintubation, and ventilator-associated pneumonia. J Trauma. 2004;56:943–52. doi:10.1097/01.TA.0000124462.61495.45.PubMedCrossRef

11.

Pronovost PJ, Angus D, Dorman T, Robinson K, Dremsizov T, Young T. Physician staffing patterns and clinical outcomes in critically ill patients: a systematic review. JAMA. 2002;288:2151–62. doi:10.1001/jama.288.17.2151.PubMedCrossRef

12.

Marshall J, Finn CA, Theodore AC. Impact of a clinical pharmacist-enforced intensive care unit sedation protocol on duration of mechanical ventilation and hospital stay. Crit Care Med. 2008;36:427–33.PubMed

13.

Burns SM, Earven S, Fisher C, Lewis R, Merrell P, Schubart JR, et al. Implementation of an institutional program to improve clinical and financial outcomes of mechanically ventilated patients: one year outcomes and lessons learned. Crit Care Med. 2003;31:2752–63. doi:10.1097/01.CCM.0000094217.07170.75.PubMedCrossRef

14.

Varelas P, Conti M, Spanaki M, Potts E, Bradford D, Sunstrom C, et al. The impact of a neurointensivist-led team on a semiclosed neurosciences intensive care unit. Crit Care Med. 2004;32:2191–8.PubMed

15.

Suarez JI, Zaidat OO, Suri MF, Feen ES, Lynch G, Hickman J, et al. Length of stay and mortality in neurocritically ill patients: impact of a specialized neurocritical care team. Crit Care Med. 2004;32:2311–7.PubMed

16.

Naidech AM, Kreiter K, Janjua N, Ostapkovich N, Parra A, Commichau C, et al. Phenytoin exposure is associated with functional and cognitive disability after subarachnoid hemorrhage. Stroke. 2005;36:583–7. doi:10.1161/01.STR.0000141936.36596.1e.PubMedCrossRef

17.

Lennihan L, Mayer SA, Fink ME, Beckford A, Paik MC, Zhang H, et al. Effect of hypervolemic therapy on cerebral blood flow after subarachnoid hemorrhage: a randomized controlled trial. Stroke. 2000;31:383–91.PubMed

18.

Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet. 1974;2:81–4. doi:10.1016/S0140-6736(74)91639-0.PubMedCrossRef

19.

Anderson CS, Huang Y, Wang JG, Arima H, Neal B, Peng B, et al. Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial. Lancet Neurol. 2008;7:391–9. doi:10.1016/S1474-4422(08)70069-3.PubMedCrossRef

20.

Gajic O, Dara SI, Mendez JL, Adesanya AO, Festic E, Caples SM, et al. Ventilator-associated lung injury in patients without acute lung injury at the onset of mechanical ventilation. Crit Care Med. 2004;32:1817–24. doi:10.1097/01.CCM.0000133019.52531.30.PubMedCrossRef

21.

The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000;342:1301–8. doi:10.1056/NEJM200005043421801.CrossRef

22.

Claassen J, Vu A, Kreiter KT, Kowalski RG, Du EY, Ostapkovich N, et al. Effect of acute physiologic derangements on outcome after subarachnoid hemorrhage. Crit Care Med. 2004;32:832–8. doi:10.1097/01.CCM.0000114830.48833.8A.PubMedCrossRef

23.

Horan TC, Gaynes RP. Surveillance of nosocomial infections. In: Mayhall CG, editor. Library of Congress: hospital epidemiology and infection control. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2004. ISBN 0-7817-4258-7.

24.

Bernard G, Artigas A, Brigham K, Carlet J, Falke K, Hudson L, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994;149:818–24.PubMed

25.

Williams Z, Chan R, Kelly E. A simple device to increase rates of compliance in maintaining 30-degree head-of-bed elevation in ventilated patients. Crit Care Med. 2008;36:1155–7. doi:10.1097/CCM.0b013e318168fa59.PubMedCrossRef

26.

Rello J, Ollendort D, Oster G, Vera-Llonch M, Bellm L, Redman R, et al. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest. 2002;122:2115–21. doi:10.1378/chest.122.6.2115.PubMedCrossRef

27.

Darouiche R, Raad I, Heard S, Thornby J, Wenker O, Gabrielli A, et al. A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group. N Engl J Med. 1999;340:1–8. doi:10.1056/NEJM199901073400101.PubMedCrossRef

28.

Commichau C, Scarmeas N, Mayer SA. Risk factors for fever in the neurologic intensive care unit. Neurology. 2003;60:837–41.PubMed

29.

Diringer MN, Reaven NL, Funk SE, Uman GC. Elevated body temperature independently contributes to increased length of stay in neurologic intensive care unit patients. Crit Care Med. 2004;32:1489–95. doi:10.1097/01.CCM.0000129484.61912.84.PubMedCrossRef

30.

Diringer MN, Neurocritical Care Fever Reduction Trial Group. Treatment of fever in the neurologic intensive care unit with a catheter-based heat exchange system. Crit Care Med. 2004;32:559–64. doi:10.1097/01.CCM.0000108868.97433.3F.PubMedCrossRef

31.

Mayer S, Kowalski RG, Presciutti M, Ostapkovich N, McGann E, Fitzsimmons BFM, et al. Clinical trial of a novel surface cooling system for fever control in neurocritical care patients. Crit Care Med. 2004;32:2508–15. doi:10.1097/01.CCM.0000147441.39670.37.PubMedCrossRef

32.

Polderman K, Rijnsburger E, Peerdeman S, Girbes A. Induction of hypothermia in patients with various types of neurologic injury with use of large volumes of ice-cold intravenous fluid. Crit Care Med. 2005;33:2744–51. doi:10.1097/01.CCM.0000190427.88735.19.PubMedCrossRef

33.

Fernandez A, Schmidt JM, Claassen J, Pavlicova M, Huddleston D, Kreiter KT, et al. Fever after subarachnoid hemorrhage: risk factors and impact on outcome. Neurology. 2007;68:1013–9. doi:10.1212/01.wnl.0000258543.45879.f5.PubMedCrossRef

34.

Kahn JM, Caldwell EC, Deem S, Newell DW, Heckbert SR, Rubenfeld GD. Acute lung injury in patients with subarachnoid hemorrhage: incidence, risk factors and outcome. Crit Care Med. 2006;34:196–202. doi:10.1097/01.CCM.0000194540.44020.8E.PubMedCrossRef

35.

Jia X, Malhotra A, Saeed M, Mark RG, Talmor D. Risk factors for ARDS in patients receiving mechanical ventilation for >48 h. Chest. 2008;133:853–61. doi:10.1378/chest.07-1121.PubMedCrossRef

36.

Zazulia AR. Hydrocephalus in ICH: what do we really know? Neurocrit Care. 2008;8:233–4. doi:10.1007/s12028-008-9055-1.PubMedCrossRef

37.

Varelas PN, Rickert KL, Cusick J, Hacein-Bey L, Sinson G, Torbey M, et al. Intraventricular hemorrhage after aneurysmal subarachnoid hemorrhage: pilot study of treatment with intraventricular tissue plasminogen activator. Neurosurgery. 2005;56:205–13. doi:10.1227/01.NEU.0000147973.83688.D8.PubMedCrossRef

Title: Medical Complications Drive Length of Stay After Brain Hemorrhage: A Cohort Study
Authors: Andrew M. Naidech
Bernard R. Bendok
Paul Tamul
Sarice L. Bassin
Charles M. Watts
H. Hunt Batjer
Thomas P. Bleck
Publication date: 01-02-2009
Publisher: Humana Press Inc
Published in: Neurocritical Care / Issue 1/2009
Print ISSN: 1541-6933
Electronic ISSN: 1556-0961
DOI: https://doi.org/10.1007/s12028-008-9148-x

At a glance: The STEP trials

Springer Medicine

Medical Complications Drive Length of Stay After Brain Hemorrhage: A Cohort Study

Abstract

Introduction

Methods

Results

Conclusion

At a glance: The STEP trials

Springer Medicine

Abstract

Introduction

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2009

Implications of Early Versus Late Bilateral Pulmonary Infiltrates in Patients with Aneurysmal Subarachnoid Hemorrhage

Early Hyperglycemia and Intravenous Insulin—The Rationale and Management of Hyperglycemia for Spontaneous Intracerebral Hemorrhage Patients: Is Time for Change?

Perioperative Use of Recombinant Factor VII to Prevent Intraoperative Aneurysm Rupture in High Risk Patients: A Preliminary Safety Evaluation

Intravenous Levetiracetam Terminates Refractory Focal Status Epilepticus

Near-Infrared Spectroscopy can Monitor Dynamic Cerebral Autoregulation in Adults

The Parkinsonism-Hyperpyrexia Syndrome